Back to Results

Ryman Healthcare Ltd ADR (RYHTY)

Ryman Healthcare Ltd ADR is an American depositary receipt linked to Ryman Healthcare Limited ordinary shares and traded over the counter on OTC Markets. Ryman Healthcare Limited develops, owns, and operates retirement villages, rest homes, and hospitals serving older adults in New Zealand and Australia. Its communities include apartments, townhouses, assisted-living accommodation, and serviced apartments, along with care facilities that provide rest home care, hospital services, specialist dementia care, and respite care. Founded in 1984 and based in Christchurch, New Zealand, the issuer focuses on integrated senior living and care operations across its core markets.


Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
Ticker Fair Value Fair Value Upside/Downside Fair Value Rating Analyst Price Target Analyst Target Upside/Downside Overall Financial Health Dividend Yield Next Earnings Date Price-to-Book Ratio Price-to-Sales Ratio Market Cap Enterprise Value Total Debt / Total Capital Free Float / Shares Outstanding Altman Z-Score Free Cash Flow / Net Income
OTC-RYHT.Y
$7.79
27.5% Upside
Undervalued
Not available
Not available
Good
0.0%
November 27, 2026
0.5x
2.4x
1.18 B
2.09 B
43.5%
99.0%
1.1
-164.5%
Valuation • Fair Value

Ryman Healthcare Ltd ADR (OTC-RYHT.Y) Fair Value by Valuation Model

Review the available estimates for Ryman Healthcare Ltd ADR (OTC-RYHT.Y), including DCF Fair Value, Comps Fair Value.

Primary Valuation Read

Fair Value

$7.79

Estimated upside of 27.5% versus the current market price.

Fair Value Confidence

Med

Confidence level for the primary fair value estimate.

DCF Fair Value

$9.53

Discounted cash flow valuation reference.

Comps Fair Value

$6.34

Comparable-company valuation reference.

Analyst Price Target

Not available

Data is currently unavailable.

How to read these valuation models

Use the 4 available valuation references for Ryman Healthcare Ltd ADR (OTC-RYHT.Y) as analytical inputs, not a standalone conclusion. Valuation methods can differ because they rely on different assumptions, time horizons and financial inputs; compare the estimates with the current price and the company’s financial quality.

Profitability • Growth

Profitability & Growth for Ryman Healthcare Ltd ADR (OTC-RYHT.Y)

Review the profitability and growth indicators currently supported by the latest data.

Revenue

491 M

Current operating scale indicator.

Revenue Forecast

526.1 M

Forward revenue estimate.

EBITDA

44.776 M

Current operating profitability reference.

EBITDA Forecast

51.827 M

Forward operating profitability estimate.

How to read profitability and growth

This section helps investors review Ryman Healthcare Ltd ADR (OTC-RYHT.Y) from an operating perspective by combining current scale, forward revenue expectations and EBITDA-related profitability measures.

Quality • Risk

Quality & Financial Risk for Ryman Healthcare Ltd ADR (OTC-RYHT.Y)

Review the financial quality and risk indicators currently supported by the latest data.

Financial Health

Good

Positive financial-health read.

Piotroski Score

6

Mid-range quality score.

Altman Z-Score

1.1

Lower score that deserves closer risk review.

FCF / Net Income

-164.5%

Cash conversion quality indicator.

How to read quality and risk

This section combines quality, balance-sheet and accounting-risk indicators for Ryman Healthcare Ltd ADR (OTC-RYHT.Y). Read the metrics together: no single score is a complete investment conclusion, but the combined view can highlight financial strength, earnings quality and areas that may deserve closer review.

Events • Dividends

Upcoming Events & Dividends for Ryman Healthcare Ltd ADR (OTC-RYHT.Y)

Track the upcoming dates and dividend metrics currently supported by the latest data.

Next Earnings Date

November 27, 2026

Days to Earnings

66

Dividend Yield

0.0%

No current dividend yield is indicated.

How to read events and dividends

This section helps investors track time-sensitive items for Ryman Healthcare Ltd ADR (OTC-RYHT.Y), including the next earnings date and dividend-related milestones. These items can matter for short-term volatility, income planning and event-driven positioning.

Technical Outlook

Technical Signals by Time Frame

Review the technical signals currently available for this stock across supported time frames.

Technical Signals by Time Frame

Switch between time frames to review the current technical signal for the stock.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 15-minute • intraday
Strong Sell

The 15-minute technical read for Ryman Healthcare Ltd ADR (OTC-RYHT.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: 1-hour • short-term
Strong Sell

The 1-hour technical read for Ryman Healthcare Ltd ADR (OTC-RYHT.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: daily • daily
Strong Sell

The daily technical read for Ryman Healthcare Ltd ADR (OTC-RYHT.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: weekly • weekly
Strong Sell

The weekly technical read for Ryman Healthcare Ltd ADR (OTC-RYHT.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

Strong Sell Sell Neutral Buy Strong Buy
Time frame: monthly • monthly
Strong Sell

The monthly technical read for Ryman Healthcare Ltd ADR (OTC-RYHT.Y) is currently Strong Sell. Use it as a timing signal only, and compare it with valuation, fundamentals and upcoming events before drawing a broader view.

FAQ • Fast Investor Answers

Ryman Healthcare Ltd ADR (OTC-RYHT.Y) Stock FAQ

Data-supported answers about Ryman Healthcare Ltd ADR (OTC-RYHT.Y), including explicit coverage status where a reliable valuation estimate is not currently available.

Fair Value
$7.79
Estimated upside 27.5%
Valuation Rating
Undervalued
Estimated upside of 27.5%
Financial Health
Good
Current financial-health read

The current fair value estimate for Ryman Healthcare Ltd ADR (OTC-RYHT.Y) is $7.79. This implies an estimated upside of 27.5% versus the current market price.

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 27.5% versus the current market price.

The current financial health read for Ryman Healthcare Ltd ADR (OTC-RYHT.Y) is Good. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

The next earnings date currently listed for Ryman Healthcare Ltd ADR (OTC-RYHT.Y) is November 27, 2026.

The latest available data indicates no current dividend yield for Ryman Healthcare Ltd ADR (OTC-RYHT.Y).

The current market capitalization listed for Ryman Healthcare Ltd ADR is 1.18 B.

The current enterprise value listed for Ryman Healthcare Ltd ADR is 2.09 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

The ticker symbol for Ryman Healthcare Ltd ADR is OTC-RYHT.Y, and the stock is listed on OTC Markets.

Ryman Healthcare Ltd ADR (OTC-RYHT.Y) is listed on OTC Markets.

The current debt-to-total-capital ratio listed for Ryman Healthcare Ltd ADR is 43.5%, which helps investors evaluate the company’s financing structure and leverage profile.

The free float listed for Ryman Healthcare Ltd ADR is 99.0%. Free float helps investors understand how much of the share base is available for public trading.

Similar Healthcare Providers & Services Stocks View more on OTC Markets

Comparable companies from the same industry, limited to one security per issuer.

UNH NYSE Unitedhealth Group Fair Value Undervalued Market Cap 334.8 B
CVS NYSE CVS Health Corp Fair Value Undervalued Market Cap 111.4 B
MCK NYSE McKesson Corporation Fair Value Undervalued Market Cap 103.9 B
HCA NYSE HCA Holdings Inc Fair Value Fair Market Cap 94.854 B
ELV NYSE Elevance Health Inc Fair Value Fair Market Cap 87.275 B
CI NYSE Cigna Corp Fair Value Bargain Market Cap 72.333 B
COR NYSE Cencora Inc Fair Value Fair Market Cap 60.002 B
CAH NYSE Cardinal Health Inc Fair Value Fair Market Cap 51.415 B
HUM NYSE Humana Inc Fair Value Fair Market Cap 44.67 B
CNC NYSE Centene Corp Fair Value Undervalued Market Cap 31.27 B
DGX NYSE Quest Diagnostics Incorporated Fair Value Fair Market Cap 25.911 B
LH NYSE Labcorp Holdings Inc Fair Value Fair Market Cap 25.266 B
GH NASDAQ Guardant Health Inc Fair Value Overvalued Market Cap 23.774 B
THC NYSE Tenet Healthcare Corporation Fair Value Fair Market Cap 21.101 B
EHC NYSE Encompass Health Corp Fair Value Fair Market Cap 12.111 B
FMS NYSE Fresenius Medical Care Corporation Fair Value Undervalued Market Cap 11.925 B
BTSG NASDAQ Brightspring Health Services Inc Fair Value Fair Market Cap 11.79 B
DVA NYSE DaVita HealthCare Partners Inc Fair Value Fair Market Cap 11.716 B
UHS NYSE Universal Health Services Inc Fair Value Undervalued Market Cap 10.567 B
ENSG NASDAQ The Ensign Group Inc Fair Value Fair Market Cap 10.19 B